A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) — Stella
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(138 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama
UCLA Hematology/Oncology - Santa Monica, Los Angeles, California
Local Institution - 0050, Orange, California
Local Institution - 0223, Washington D.C., District of Columbia
Baptist MD Anderson Cancer Center, Jacksonville, Florida
University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida
Local Institution - 0228, Orlando, Florida
Winship Cancer Institute, Emory University, Atlanta, Georgia
Louisiana State University Health Sciences Shreveport, Shreveport, Louisiana
Boston Medical Center, Boston, Massachusetts
Local Institution - 0219, Minneapolis, Minnesota
Local Institution - 0229, New York, New York
Local Institution - 0221, Stony Brook, New York
Argentina
Hospital Italiano de Buenos Aires, ABB, Buenos Aires F.D.
Local Institution - 0214, ABB, Buenos Aires F.D.
Hospital Aleman, Buenos Aires, Buenos Aires F.D.
Australia
Royal Prince Alfred Hospital, Camperdown, New South Wales
Liverpool Hospital, Liverpool, New South Wales
Princess Alexandra Hospital, Brisbane, Queensland
Royal Adelaide Hospital, Adelaide, South Australia
Monash Health, Clayton, Victoria
Peter MacCallum Cancer Centre, Melbourne, Victoria
The Alfred Hospital, Melbourne, Victoria
Fiona Stanley Hospital, Murdoch, Western Australia
Austria
Ordensklinikum Linz GmbH Elisabethinen, Linz, Upper Austria
Hanusch-Krankenhaus, Vienna
Belgium
Antwerp University Hospital, Edegem, Antwerpen
Local Institution - 0217, Brussels, Bruxelles-Capitale, Région de
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne, Yvoir, Namur
UZ Gent, Ghent, Oost-Vlaanderen
Brazil
Local Institution - 0012, Nova Lima, Minas Gerais
A. C. Camargo Cancer Center, São Paulo, São Paulo
Local Institution - 0103, São Paulo, São Paulo
Local Institution - 0031, São Paulo
Canada
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta
Vancouver General Hospital, Vancouver, British Columbia
QEII Health Sciences Centre - Victoria General Site, Halifax, Nova Scotia
Local Institution - 0192, Hamilton, Ontario
CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal, Quebec
Czechia
Fakultní nemocnice Brno Bohunice, Brno, Brno-město
Local Institution - 0093, Hradec Králové, Hradec Králové
Vseobecna fakultni nemocnice v Praze, Prague
Denmark
Rigshospitalet, Copenhagen, Capital Region
Aarhus Universitetshospital, Skejby, Aarhus, Central Jutland
Roskilde Sygehus, Roskilde, Region Sjælland
Odense Universitetshospital, Odense, Region Syddanmark
Finland
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa
Oulun yliopistollinen sairaala, Oulu
Turku University Hospital, Turku
France
Hopital Claude Huriez - CHU de Lille, Lille, Nord
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Pays de la Loire Region